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RNA interference (RNAi) is a conserved biological response 
to double-stranded RNAs that results in posttranscriptional 
silencing  of  target  gene  expression.  Double-stranded 
processed RNAs of 21-23 nt were found to affect in a non-
specific  manner  a  number  of  signaling  and  transcription 
pathways, including interferon and PKR cascades. We report 
here  that  siRNAs  induce  the  expression  of  general 
transcription factor TRF3, which can trigger an interferon 
response in mammalian cells.
TRF3 is a recently discovered general transcription factor 
with  vertebrate  restricted  expression.  TBP  and  TRF3 
transcription  factors  have  almost  identical  carboxy-
terminal domains and diverge significantly in their amino 
terminal regions1,  2. The role of TRF3 in gene regulation 
remains  to  be  determined,  but  antisense  experiments 
employing zebrafish as a model system revealed that TRF3 is 
required for the embryonic development3. To identify TRF3-
regulated genes in mammalian cell we attempted to knockdown 
TRF3 expression by sequence-specific siRNAs. Unexpectedly, 
after  using  several  TRF3-specific  dsRNAs  transfected  at 
different concentrations for various time periods, we found 
that TRF3 protein expression remained unaffected and even 
slight increase has been observed in siRNA-treated cells 
(Fig. 1a, b). In contrast, siRNA-mediated knockdown of TBP 
was very efficient under the same experimental conditions. 
To clarify this issue, HeLa and 293T cell lines have been 
transfected  with  an  expression  vector  containing  flag-
tagged TRF3 minigene and treated with TRF3-specific siRNAs. 
Western blotting with a flag specific antibody showed that 
the expression of endogenously expressed TRF3 was reduced 
to  almost  undetectable  levels  following  two  consecutive 
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transfections  with  50  nM  TRF3  siRNAs,  (Fig.  1c) 
(Supplementary Figure 1). 
The  apparent  inability  to  silence  the  endogenous  TRF3 
expression raised the possibility that either TRF3 mRNA is 
inaccessible to siRNAs or TRF3 gene might be upregulated by 
dsRNA treatment, as reported for other genes4-6. We therefore 
analyzed TRF3 mRNA levels after transfection with either a 
luciferase or a randomized nonspecific control siRNA. The 
results of Figure 1d show that at 50 nM concentration the 
nonspecific siRNAs induced the expression of TRF3. When the 
concentration of siRNA was reduced to 20 nM, expression of 
TRF3  was  still  upregulated  after  three  consecutive 
transfections.  Thus,  TRF3  expression  is  specifically 
induced  by  chemically  synthesized  siRNAs  in  a  sequence-
independent manner.
We next searched to determine whether the induction of TRF3 
expression  is  time  dependent.  Time-course  experiments 
depicted in Figure 1e revealed that a significant increase 
in mRNA levels was observed 24 h after treatment with 100 
nM siRNA duplexes. TRF3 expression accumulated over the 72-
h  time-course  with  highest  concentrations  detected  72  h 
after siRNA application. Thus, the effect of siRNAs on TRF3 
expression is sustainable and leads to a substantial TRF3 
mRNA buildup.
siRNAs  and  shRNAs  have  been  found  to  affect  several 
regulatory  pathways  that  partially  overlap  with  the 
interferon  regulated  cascades.  Therefore,  we  next  tested 
whether an interferon response could be triggered by TRF3. 
ISG54,  ISG20  and  OAS1  are  classic  interferon-responsive 
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genes that have been reported previously to be affected by 
siRNA and shRNA treatments. We transfected HeLa cells with 
a TRF3 expression vector and carried out RT-PCR analysis 
for ISG54, ISG20 and OAS1 mRNAs. ISG54 mRNA levels were 
induced  approximately  4-fold  by  TRF3  expression  vector, 
whereas ISG20 and OAS1 levels remained unchanged (Fig. 1f).
To  test  whether  the  induction  of  ISG54  expression  was 
attributed  directly  to  the  promoter  transactivation  by 
TRF3,  we  cotransfected  TRF3  expression  vector  with  a 
luciferase reporter driven by ISG54 promoter. The results 
of Figure 1g show that TRF3 activated the ISG54 promoter by 
4-fold, compared with ISG54-luciferase plasmid transfected 
cells. In contrast, TBP and TRF2 expression vectors failed 
to  induce  ISG54  reporter  under  the  same  experimental 
conditions.  Thus,  the  activation  of  interferon-responsive 
gene ISG54 is dependent on TRF3.
Next,  we  examined  directly  the  presence  of  TRF3  at  the 
ISG54 locus  in vivo.  The human ISG54 promoter contains a 
non-canonical TATA box located approximately 20 bp upstream 
of transcription start site.  Chromatin immunoprecipitation 
analysis  (ChIP) with specific antibodies confirmed TRF3 
association with ISG54 promoter chromatin (Fig. 1h). ChIP 
analysis with TBP antibodies failed to detect TBP binding 
to  the  promoter  elements,  as  reported  by  others7.  Thus, 
ISG54 is  a  direct  and  selective  TRF3  target  gene  in 
mammalian  cells.  It  is  also  worth  noting  that  the  non-
canonical TATA box sequence is evolutionary conserved in 
ISG54 genes from other species8.
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Finally,  we  determined  whether  the  induction  of  TRF3 
transcription by small dsRNAs depends on Ago2 presence, as 
recently  reported9.  We  used  specific  siRNAs  to  knockdown 
Ago2 and Dicer expression in HeLa cells and analyzed TRF3 
expression by RT-PCR. The results shown in Supplementary 
Figure  2  indicate  that  Ago2  downregulation  reduced  the 
increase of TRF3 expression by siRNAs. In contrast, Dicer 
knockdown led to significant TRF3 transcript accumulation.
In  conclusion,  we  show  that  siRNAs  can  induce  the 
expression  of  general  transcription  factor  TRF3.  TRF3 
overexpression  leads  to  activation  of  ISG54,  a  key 
interferon-responsive  gene.  It  is  possible  that  TRF3 
activation  by  dsRNAs  is  a  unique  evolutionary  conserved 
mechanism in vertebrates that ensures the rapid activation 
of  selective  genes.  This  implies  the  existence  of 
alternative  gene  network  that  is  not  limited  by  ongoing 
basal gene transcriptional machinery and is resistant to 
anticellular mechanisms that incorporate RNA as an invasive 
agent.
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Figure 1. TRF3 induction by siRNAs.
(a) TRF3 protein levels are not downregulated by TRF3-specific siRNAs. 
HeLa cells were transfected with 100 nM TRF3 siRNAs and TRF3 expression 
was monitored by Western blotting with a TRF3 specific antiserum.
(b) TBP knockdown by siRNA treatment. TBP protein levels in HeLa cells 
were determined by Western blotting after siRNA treatment. 
(c) Ectopic TRF3 expression is downregulated by TRF3 siRNAs. HeLa cells 
were transfected with a flag-tagged TRF3 expression vector and TRF3 
expression  was  analyzed  by  Western  blotting  with  a  flag-specific 
antibody 72 h after siRNA application.
(d)  Concentration-dependence  of  siRNA-induced  induction  of  TRF3 
expression. HeLa cells were transfected with varying concentrations of 
non-specific siRNA and TRF3 expression was determined by RT-PCR.
(e)  Time-course  analysis  of  siRNA-induced  expression  of  TRF3.  TRF3 
expression  was  monitored  by  RT-PCR  after  100  nM  non-specific  siRNA 
treatment.
(f)  Endogenous ISG54 expression is induced by overexpression of TRF3. 
Hela cells were transfected with a TRF3 expression vector and ISG54, 
ISG20 and OAS1 mRNA levels were analyzed by RT-PCR.
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(g)  ISG54  promoter  activity  is  induced  by  TRF3.  HeLa  cells  were 
transfected  with  ISG54-luciferase  vector  and  expression  constructs 
encoding TRF3, TBP and TRF2. Luciferase activity was measured 48 h 
after transfection.
(h)  Association of TRF3 with ISG54 promoter in asynchronous HeLa and 
293T  cells  transfected  with  a  flag-tagged  TRF3  and  TBP  expression 
vectors. ChIP analysis was performed with primer pair flanking the non-
canonical TATA box element. Monoclonal haemagglutinin (HA) antibody was 
used a negative control.
Supplementary Online Material
Supplementary Figure 1. 
(a)TRF3 protein levels are not downregulated by TRF3-specific siRNAs in 
293T cells. 
(b) TBP knockdown by siRNA treatment in 293T cells. 
(c) Downregulation of ectopic TRF3 expression by TRF3 siRNAs.
Supplementary Figure 2.
TRF3 mRNA upregulation by non-specific siRNAs requires Ago2 protein. 
HeLa cells were transfected with 100 nM Ago2 and Dicer siRNAs for 72 h 
and TRF3 expression was assessed by RT-PCR. Ago2 and Dicer expression 
levels after siRNA treatments were analyzed by Western blotting and RT-
PCR, respectively.
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Supplementary Table 1. List of primer sequences.
_____________________________________________________
RT-PCR primers
_____________________________________________________
TRF3
Pr1 5’-CCT-GAG-AAA-CCA-AAC-TCC-GAC-T-3’
Pr2 5’-TTC-TTT-GGC-ACC-TGT-CAA-CAC-AAC-3’
OAS1
Pr1 5’-TCT-GCA-TCA-GGA-GGT-GGA—GT-3’
Pr2 5’-GTC-CAG-TAG-ATT-CGA-AGA-TG-3’
ISG20
Pr1 5’-TAG-AGA-TGA-GTC-ACC-GCT-GA-3’
Pr2 5’-GAT-GCT-CTT-GTG-CAG-GAG-G-3’
ISG54
Pr1 5’-CTG-AAG-AGT-GCA-GCT-GCC-TG-3
Pr2 5’-CAC-TTT-AAC-CTG-GTC-CAC-CC-3’
GAPDH
Pr1 5’-ACC-ACA-GTC-CAT-GCC-ATC-AC-3’
Pr2 5’-TCC-ACC-ACC-CTG-TTG-CTG-TA-3’
_____________________________________________________
Chromatin IP (ChIP) primer
_____________________________________________________
ISG54 promoter
Pr1 5’-CTC-CGG-AGG-AAA-AAG-AGT-CCT-C-3’
Pr2 5’-AAA-TCT-TCC-TCT-TCT-GCC-ACC-3
_____________________________________________________
siRNA primers
_____________________________________________________
TRF3  duplex 1
Pr1 5’-GuG-AAG-AGC-AGU-CTC-GAC-UTT-3’
Pr2 5’-AGU-CGA-GAC-UGC-UCU-UCA-CTT-3’
TRF3 duplex 2
Pr1 5’-ACA-GCU-GGA-UUC-UUC-UAC-GTT-3’
Pr2 5’-CGU-AGA-AGA-AUC-CAG-CUG-UTT-3’
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TBP duplex
Pr1 5’-GAG-GAU-AAG-AGA-GCC-ACG-AAC-TT-3’ 
Pr2 5’-TTG-UUC-GUG-GCU-CUC-UUA-UCC-UC-3
Dicer duplex
Pr1 5’-CAT-GGA-TAG-TGG-GAT-GTC-AC-3’
Pr2 5’-CTA-CTT-CCA-CAG-TGA-CTC-TG-3’
Ago2 duplex
Pr1  5’-GCA-CGG-AAG-UCC-AUC-UGA-AUU-3’
Pr2 5’- pUUC-AGA-UGG-ACU-UCC-GUG-CUU-3
Non-specific duplex
Pr1 5'-AAU-UUU-UUU-CCC-CAA-AGG-GGG-3
Pr2 5'-AAC-CCC-CUU-UGG-GGA-AAA-AAA-3'
____________________________________________________
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